2 ASX shares experts think have sold off too much

Which stocks have seen their value plummet even though the underlying businesses have not changed one iota? This pair.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's shocking enough the S&P/ASX 200 Index (ASX: XJO) has sunk 5.8% so far this year.

But with mining and financial shares dragging the index up, there are hundreds of ASX shares that have fallen far more than that.

Some former market darlings, especially ASX growth stocks, have seen their valuations halve, if not worse.

But are we now at a point where some of those businesses have been punished too much? Perhaps the stock price has lost all sense of the company's outlook?  

A couple of experts recently each picked out an ASX share they think are in that position and are ripe to buy right now:

A man in a business suit wearing boxing gloves slumps in the corner of a boxing ring representing the beaten-up Zip share price in recent times

Image source: Getty Images

'Unjustly' sold off

To Montgomery Investment Management portfolio manager Gary Rollo, Symbio Holdings Ltd (ASX: SYM) looks way too cheap at the moment.

The software maker has seen its share price plunge 38.7% this calendar year.

"It's been sold off so hard because the comparators, the overseas players that do what it does, they're at a different stage in their life cycle than the Symbio is," Rollo told a Livewire video.

"So this business has had its valuation regime adjusted, I think unjustly, without reflecting on the fundamentals."

Rollo doesn't detect any change to the business or its outlook compared to before the stock price fall.

"It's a $350 million market cap. It's got $50 million of cash on the balance sheet, so we don't have a capital structure question," he said.

"It's on 8.5 to 9 times EBITDA [earnings before interest, tax, depreciation, and amortisation]… so it doesn't have a valuation question."

Symbio's hot growth opportunity is in Asia and that hasn't diminished.

"But you're not paying for it and so we like the look of that and that's our tip for now." 

'Capital-light, high growth' business

QVG Capital portfolio manager Josh Clark picked Johns Lyng Group Ltd (ASX: JLG) as a current bargain.

Johns Lyng shares have fallen a shocking 37.5% just this month.

"Yeah, absolutely it's been sold off, [from] the $9 range into the mid-$5s or thereabouts, so the valuation's actually starting to look much more compelling."

As a service provider to insurance companies, Johns Lyng was recognised by the market as a star in recent years.

Clark admits that did make the ASX share expensive before May started.

"But they haven't seen a change to their earnings. They're still going to hit their earnings guidance," he said.

"I think part of the sell-off is the market's having a bit of a hissy fit that there's no upgrade near term… Also management has sold some stock."

Clark urged investors to look past the recent share price movements.

"If you focus too much on that, you're missing the forest for the trees," he said.

"It's still a really capital-light, high growth services business. I've said this a lot, but owner, founder-led, which is really important and these guys have just got more irons in the fire than you can count."

Motley Fool contributor Tony Yoo has positions in Johns Lyng Group Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Johns Lyng Group Limited and Symbio Holdings Limited. The Motley Fool Australia has positions in and has recommended Symbio Holdings Limited. The Motley Fool Australia has recommended Johns Lyng Group Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Man sitting in a plane seat works on his laptop.
Broker Notes

Down 34% in 2026, are Virgin Australia shares a good buy today?

A leading analyst delivers his outlook for Virgin Australia’s beaten-down shares.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

Brokers name 3 ASX shares to buy right now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A smiling woman holds a Facebook like sign above her head.
Broker Notes

Why these ASX shares are rated as buys in April

Let's see what makes them bullish on these names right now.

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Broker Notes

Are CBA shares still a good buy for passive income?

A leading analyst delivers his verdict on CBA’s passive income appeal.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Morgans names 2 ASX shares to buy and 1 to accumulate

What is the broker recommending investors do with these shares?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

2 ASX 200 shares to buy ahead of anticipated rally: expert

After a 9.1% drop between 27 February and 23 March, the ASX 200 reversed course last Tuesday.

Read more »

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

Bell Potter says this ASX 200 stock can rise 38% and pay a 6% dividend yield

Major upside and a generous dividend yield could be on offer with this name.

Read more »